{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:15:46Z","timestamp":1767212146844,"version":"3.37.3"},"reference-count":40,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:00:00Z","timestamp":1514505600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG019695","R01 AG029362","R01 AG031763","P30 DK0504567"],"award-info":[{"award-number":["R01 AG019695","R01 AG029362","R01 AG031763","P30 DK0504567"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR00135"],"award-info":[{"award-number":["UL1 TR00135"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1210\/js.2017-00457","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T14:08:55Z","timestamp":1514470135000},"page":"154-165","source":"Crossref","is-referenced-by-count":11,"title":["Effects of Toremifene, a Selective Estrogen Receptor Modulator, on Spontaneous and Stimulated GH Secretion, IGF-I, and IGF-Binding Proteins in Healthy Elderly Subjects"],"prefix":"10.1210","volume":"2","author":[{"given":"Ferdinand","family":"Roelfsema","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Section of Endocrinology and Metabolism, Leiden University Medical Center, Leiden, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J","family":"Yang","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, Mayo School of Graduate Medical Education, Center for Translational Science Activities, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Y","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Primary Care Internal Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Erickson","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril Y","family":"Bowers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes D","family":"Veldhuis","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, Mayo School of Graduate Medical Education, Center for Translational Science Activities, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"issue":"6","key":"2019041123191217400_B1","first-page":"717","article-title":"Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human","volume":"19","author":"Giustina","year":"1998","journal-title":"Endocr Rev"},{"issue":"7","key":"2019041123191217400_B2","first-page":"3143","article-title":"Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin\u2019s dose-dependent inhibition of fasting growth hormone secretion","volume":"86","author":"Bray","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123191217400_B3","first-page":"551","article-title":"Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women","volume":"86","author":"Anderson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041123191217400_B4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/jc.2003-031291","article-title":"Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive","volume":"89","author":"Veldhuis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123191217400_B5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/jcem.87.2.8222","article-title":"Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men","volume":"87","author":"Gentili","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123191217400_B6","first-page":"513","article-title":"Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence","volume":"79","author":"Metzger","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041123191217400_B7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200039050-00002","article-title":"Clinical pharmacokinetics of toremifene","volume":"39","author":"Taras","year":"2000","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"2019041123191217400_B8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14740338.2015.1014799","article-title":"Selective estrogen receptor modulators in clinical practice: a safety overview","volume":"14","author":"Ellis","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"2019041123191217400_B9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.juro.2010.06.022","article-title":"Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer","volume":"184","author":"Smith","year":"2010","journal-title":"J Urol"},{"issue":"1","key":"2019041123191217400_B10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1186\/s12885-015-1871-z","article-title":"Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial","volume":"15","author":"Fujimura","year":"2015","journal-title":"BMC Cancer"},{"issue":"3","key":"2019041123191217400_B11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0022-4731(90)90018-N","article-title":"Hormonal effects of toremifene in breast cancer patients","volume":"36","author":"Sz\u00e1mel","year":"1990","journal-title":"J Steroid Biochem"},{"issue":"2","key":"2019041123191217400_B12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0959-8049(94)90077-9","article-title":"Influence of toremifene on the endocrine regulation in breast cancer patients","volume":"30A","author":"Sz\u00e1mel","year":"1994","journal-title":"Eur J Cancer"},{"issue":"3","key":"2019041123191217400_B13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0306-9877(02)00215-3","article-title":"Estrogen agonists\/antagonists may down-regulate growth hormone signaling in hepatocytes\u2014an explanation for their impact on IGF-I, IGFBP-1, and lipoprotein(a)","volume":"61","author":"McCarty","year":"2003","journal-title":"Med Hypotheses"},{"issue":"10","key":"2019041123191217400_B14","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123191217400_B15","doi-asserted-by":"crossref","first-page":"E538","DOI":"10.1152\/ajpendo.00071.2009","article-title":"Sensitivity and specificity of pulse detection using a new deconvolution method","volume":"297","author":"Liu","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041123191217400_B16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0076-6879(00)21192-0","article-title":"Irregularity and asynchrony in biologic network signals","volume":"321","author":"Pincus","year":"2000","journal-title":"Methods Enzymol"},{"issue":"3","key":"2019041123191217400_B17","doi-asserted-by":"crossref","first-page":"R721","DOI":"10.1152\/ajpregu.2001.280.3.R721","article-title":"Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans","volume":"280","author":"Veldhuis","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"2019041123191217400_B18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1203\/00006450-199012000-00018","article-title":"Increased hGH production rate after low-dose estrogen therapy in prepubertal girls with Turner\u2019s syndrome","volume":"28","author":"Mauras","year":"1990","journal-title":"Pediatr Res"},{"issue":"5","key":"2019041123191217400_B19","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/jcem.83.5.4761","article-title":"Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women","volume":"83","author":"Ovesen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041123191217400_B20","first-page":"2227","article-title":"The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals","volume":"81","author":"van Kesteren","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041123191217400_B21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1210\/jc.2007-1322","article-title":"Pituitary and\/or peripheral estrogen-receptor \u03b1 regulates follicle-stimulating hormone secretion, whereas central pathways direct growth hormone and prolactin secretion in postmenopausal women","volume":"93","author":"Cosma","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041123191217400_B22","first-page":"1407","article-title":"Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization","volume":"76","author":"Weissberger","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041123191217400_B23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/jc.2008-2108","article-title":"Aromatase and 5\u03b1-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men","volume":"94","author":"Veldhuis","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123191217400_B24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1210\/en.2003-0646","article-title":"Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement","volume":"145","author":"Yan","year":"2004","journal-title":"Endocrinology"},{"key":"2019041123191217400_B25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jsbmb.2017.03.021","article-title":"Twenty years of the G protein-coupled estrogen receptor GPER: historical and personal perspectives","volume":"176","author":"Barton","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"2019041123191217400_B26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/eje.0.1390309","article-title":"Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer","volume":"139","author":"Corsello","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2019041123191217400_B27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1530\/EJE-15-0426","article-title":"Estrogen receptor antagonism uncovers gender-dimorphic suppression of whole body fat oxidation in humans: differential effects of tamoxifen on the GH and gonadal axes","volume":"173","author":"Birzniece","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2019041123191217400_B28","doi-asserted-by":"crossref","first-page":"E521","DOI":"10.1210\/jc.2011-3347","article-title":"Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators","volume":"97","author":"Birzniece","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041123191217400_B29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1365-2265.2000.00991.x","article-title":"Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer","volume":"52","author":"De Marinis","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2019041123191217400_B30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2265.1993.tb02410.x","article-title":"Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women","volume":"39","author":"Kelly","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2019041123191217400_B31","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1210\/jc.2001-011885","article-title":"Impact of experimental blockade of peripheral growth hormone (GH) receptors on the kinetics of endogenous and exogenous GH removal in healthy women and men","volume":"87","author":"Veldhuis","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041123191217400_B32","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1210\/jc.2005-0173","article-title":"Comparison of the metabolic effects of raloxifene and oral estrogen in postmenopausal and growth hormone-deficient women","volume":"90","author":"Gibney","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041123191217400_B33","first-page":"2286","article-title":"Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study","volume":"84","author":"Vestergaard","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041123191217400_B34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1365-2265.1996.8610870.x","article-title":"Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study","volume":"45","author":"Helle","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2019041123191217400_B35","first-page":"2848","article-title":"Effects of oral versus transdermal estrogen on the growth hormone\/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study","volume":"81","author":"Bellantoni","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041123191217400_B36","first-page":"1918","article-title":"Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex","volume":"85","author":"Kam","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041123191217400_B37","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1210\/jc.2004-1314","article-title":"Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I\/IGFBP-1 concentrations","volume":"90","author":"Veldhuis","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123191217400_B38","first-page":"700","article-title":"Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1\u201344)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states","volume":"86","author":"Evans","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2-4","key":"2019041123191217400_B39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0955-2235(96)00006-3","article-title":"Regulation of IGFBP-1 in humans","volume":"6","author":"Brismar","year":"1995","journal-title":"Prog Growth Factor Res"},{"issue":"3-4","key":"2019041123191217400_B40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000438904","article-title":"Growth hormone dynamics in healthy adults are related to age and sex and strongly dependent on body mass index","volume":"103","author":"Roelfsema","year":"2016","journal-title":"Neuroendocrinology"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/2\/2\/154\/23683469\/js.2017-00457.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T14:22:28Z","timestamp":1555078948000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/2\/2\/154\/4780793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,28]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,12,28]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/js.2017-00457","relation":{},"ISSN":["2472-1972"],"issn-type":[{"type":"electronic","value":"2472-1972"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,12,28]]}}}